Company Valuation: COSMOS Pharmaceutical Corporation

Data adjusted to current consolidation scope
Fiscal Period: May 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 483,107 525,081 502,890 700,001 476,495 503,283 - -
Change - 8.69% -4.23% 39.2% -31.93% 5.62% - -
Enterprise Value (EV) 1 450,132 497,354 477,918 692,920 476,495 537,683 540,702 546,233
Change - 10.49% -3.91% 44.99% -31.23% 12.84% 0.56% 1.02%
P/E 20.9x 22.1x 20.6x 22.6x 14.9x 15.7x 14.8x 13.9x
PBR 2.54x 2.49x 2.17x 2.72x 1.68x 1.63x 1.5x 1.38x
PEG - 7.98x 7.61x 0.8x 4.32x 56.66x 2.4x 2.14x
Capitalization / Revenue 0.64x 0.63x 0.52x 0.69x 0.43x 0.43x 0.4x 0.37x
EV / Revenue 0.6x 0.6x 0.5x 0.69x 0.43x 0.46x 0.43x 0.4x
EV / EBITDA 10x 10.5x 9.29x 11.1x 7.12x 7.59x 7.12x 6.72x
EV / EBIT 15.1x 16.5x 15.2x 17.1x 11.3x 12.1x 11.5x 10.8x
EV / FCF -39.1x 93.5x -222x -807x -20.6x -68.1x -186x -862x
FCF Yield -2.56% 1.07% -0.45% -0.12% -4.85% -1.47% -0.54% -0.12%
Dividend per Share 2 40 50 60 70 82 85.3 90.01 94.2
Rate of return 0.66% 0.75% 0.95% 0.79% 1.36% 1.34% 1.42% 1.48%
EPS 2 292.4 300.5 308.6 390.9 404.3 405.5 430.4 458.4
Distribution rate 13.7% 16.6% 19.4% 17.9% 20.3% 21% 20.9% 20.6%
Net sales 1 755,414 827,697 964,989 1,011,390 1,099,583 1,175,556 1,263,383 1,363,477
EBITDA 1 44,906 47,496 51,425 62,633 66,929 70,861 75,956 81,252
EBIT 1 29,796 30,128 31,501 40,404 42,353 44,406 47,189 50,384
Net income 1 23,155 23,797 24,454 30,978 32,046 32,143 34,123 36,324
Net Debt 1 -32,975 -27,727 -24,972 -7,081 - 34,400 37,419 42,950
Reference price 2 6,100.00 6,630.00 6,345.00 8,832.00 6,012.00 6,350.00 6,350.00 6,350.00
Nbr of stocks (in thousands) 79,198 79,198 79,258 79,257 79,257 79,257 - -
Announcement Date 7/11/22 7/10/23 7/12/24 7/11/25 7/13/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
15.66x0.46x7.59x1.34% 3.21B
17.04x0.7x10.38x-.--% 15.29B
23.58x0.98x10.61x1.91% 7.04B
17.07x0.76x7.93x2.19% 6.58B
21.05x0.36x5.64x2.17% 6.44B
19.76x0.72x12.44x1.1% 5.91B
16.3x1.02x7.13x2.59% 4.61B
13.93x0.59x4.53x5.19% 3.1B
14.97x0.89x6.68x4.33% 3.02B
15.76x0.33x5.23x1.39% 2.98B
Average 17.51x 0.68x 7.82x 2.22% 5.82B
Weighted average by Cap. 18.08x 0.70x 8.64x 1.68%

Y-o-Y evolution of P/E

Valuation ratios - P/E - COSMOS Pharmaceutical Corporation

Historical PBR trend

Valuation ratios - PBR - COSMOS Pharmaceutical Corporation

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - COSMOS Pharmaceutical Corporation

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - COSMOS Pharmaceutical Corporation


Year-on-year evolution of the Yield

Valuation ratios - Yield - COSMOS Pharmaceutical Corporation
  1. Stock Market
  2. Stocks
  3. 3349 Stock
  4. Valuation COSMOS Pharmaceutical Corporation